Cash flow Option Care Health, Inc.

Stocks

OPCH

US68404L2016

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 01:30:00 18/06/2026 am IST			5-day change	1st Jan Change
21.71 ^USD	+0.42%		+1.54%	-31.86%

13/05	Option Care Health, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10:40 AM
08/05	Option Care Health Insider Bought Shares Worth $499,671, According to a Recent SEC Filing	MT

e99cc17ddfc34e819.MEeTFYj9Rto1Y1BpJvdBilEJzoBNKuc8rS02xq6rBvE.aSvmWM24LeptDBMAbqg2_DZuiM8qGo5_gGNnsefaSYdDJPFi65w_uW9OZA

Published financial data: OPTION CARE HEALTH, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	343.86Cr	394.47Cr	430.23Cr	499.82Cr	564.95Cr
Total Revenues	343.86Cr	394.47Cr	430.23Cr	499.82Cr	564.95Cr
Cost of Goods Sold, Total	265.9Cr	307.78Cr	332.11Cr	398.52Cr	456.16Cr
Gross Profit	78Cr	87Cr	98Cr	101.3Cr	108.79Cr
Selling General & Admin Expenses, Total	53Cr	57Cr	61Cr	63Cr	68Cr
Depreciation & Amortization - (IS)	6.31Cr	6.06Cr	5.92Cr	6.09Cr	6.75Cr
Other Operating Expenses, Total	59Cr	63Cr	67Cr	69Cr	75Cr
Operating Income	19Cr	24Cr	31Cr	32Cr	34Cr
Interest Expense, Total	-6.7Cr	-5.38Cr	-5.12Cr	-4.9Cr	-5.46Cr
Net Interest Expenses	-6.7Cr	-5.38Cr	-5.12Cr	-4.9Cr	-5.46Cr
Income (Loss) On Equity Invest.	60.3L	51.25L	55.3L	59.64L	74.09L
Other Non Operating Income (Expenses)	13T	1.42Cr	49.65L	52.31L	-31.57L
EBT, Excl. Unusual Items	13Cr	21Cr	27Cr	28Cr	29Cr
Merger & Related Restructuring Charges	-	-	8.49Cr	-	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-1.34Cr	-	-	-4L	-47L
EBT, Incl. Unusual Items	12Cr	21Cr	36Cr	28Cr	28Cr
Income Tax Expense	-2.34Cr	5.52Cr	9.17Cr	7.18Cr	7.53Cr
Earnings From Continuing Operations	14Cr	15Cr	27Cr	21Cr	21Cr
Net Income to Company	14Cr	15Cr	27Cr	21Cr	21Cr
Net Income - (IS)	14Cr	15Cr	27Cr	21Cr	21Cr
Net Income to Common Incl Extra Items	14Cr	15Cr	27Cr	21Cr	21Cr
Net Income to Common Excl. Extra Items	14Cr	15Cr	27Cr	21Cr	21Cr
Per Share Items
Net EPS - Basic	0.78	0.83	1.49	1.23	1.28
Basic EPS - Continuing Operations	0.78	0.83	1.49	1.23	1.28
Basic Weighted Average Shares Outstanding	18Cr	18Cr	18Cr	17Cr	16Cr
Net EPS - Diluted	0.77	0.83	1.48	1.23	1.27
Diluted EPS - Continuing Operations	0.77	0.83	1.48	1.23	1.27
Diluted Weighted Average Shares Outstanding	18Cr	18Cr	18Cr	17Cr	16Cr
Normalized Basic EPS	0.45	0.71	0.96	1.03	1.11
Normalized Diluted EPS	0.45	0.71	0.95	1.03	1.1
Supplemental Items
EBITDA	26Cr	31Cr	38Cr	39Cr	41Cr
EBITA	22Cr	27Cr	35Cr	36Cr	37Cr
EBIT	19Cr	24Cr	31Cr	32Cr	34Cr
EBITDAR	29Cr	33Cr	41Cr	42Cr	44Cr
Effective Tax Rate - (Ratio)	-20.09	26.83	25.55	25.31	26.62
Current Domestic Taxes	68.17L	1.33Cr	7.67Cr	5.78Cr	6.46Cr
Total Current Taxes	68.17L	1.33Cr	7.67Cr	5.78Cr	6.46Cr
Deferred Domestic Taxes	-3.02Cr	4.19Cr	1.49Cr	1.39Cr	1.07Cr
Total Deferred Taxes	-3.02Cr	4.19Cr	1.49Cr	1.39Cr	1.07Cr
Normalized Net Income	8.12Cr	13Cr	17Cr	18Cr	18Cr
Supplemental Operating Expense Items
Net Rental Expense, Total	2.98Cr	2.91Cr	3.06Cr	3.27Cr	3.51Cr
Imputed Operating Lease Interest Expense	1.34Cr	1.08Cr	1.08Cr	1.08Cr	1.23Cr
Imputed Operating Lease Depreciation	1.64Cr	1.83Cr	1.98Cr	2.19Cr	2.28Cr
Stock-Based Comp., Other (Total)	95.75L	1.68Cr	3.05Cr	3.61Cr	4Cr
Total Stock-Based Compensation	95.75L	1.68Cr	3.05Cr	3.61Cr	4Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	12Cr	29Cr	34Cr	41Cr	23Cr
Trading Asset Securities, Total	-	-	97.46L	80.34L	55.01L
Total Cash And Short Term Investments	12Cr	29Cr	35Cr	42Cr	24Cr
Accounts Receivable, Total	34Cr	38Cr	38Cr	41Cr	47Cr
Other Receivables	4.3Cr	5.34Cr	5.2Cr	5.44Cr	3.53Cr
Total Receivables	38Cr	43Cr	43Cr	46Cr	51Cr
Inventory	18Cr	22Cr	27Cr	39Cr	47Cr
Prepaid Expenses	2.65Cr	4.49Cr	3.69Cr	4.98Cr	4.68Cr
Other Current Assets, Total	-	-	1L	-	-
Total Current Assets	71Cr	99Cr	109.43Cr	132.26Cr	126.5Cr
Gross Property Plant And Equipment	31Cr	30Cr	33Cr	33Cr	36Cr
Accumulated Depreciation	-12Cr	-12Cr	-12Cr	-12Cr	-13Cr
Net Property Plant And Equipment	19Cr	18Cr	20Cr	21Cr	23Cr
Long-term Investments	2.01Cr	1.94Cr	3.11Cr	3.12Cr	2.79Cr
Goodwill	147.76Cr	153.34Cr	154.02Cr	154.02Cr	160.67Cr
Other Intangibles, Total	37Cr	36Cr	34Cr	30Cr	31Cr
Deferred Tax Assets Long-Term	2.7Cr	-	-	-	-
Other Long-Term Assets, Total	36.33L	2.09Cr	1.13Cr	1.28Cr	1.65Cr
Total Assets	279.09Cr	311.29Cr	321.7Cr	342.17Cr	345.58Cr
Liabilities
Accounts Payable, Total	28Cr	38Cr	43Cr	61Cr	64Cr
Accrued Expenses, Total	15Cr	16Cr	17Cr	14Cr	16Cr
Current Portion of Long-Term Debt	66.01L	60L	60L	65.12L	67.8L
Current Portion of Leases	1.91Cr	1.94Cr	1.83Cr	2.2Cr	2.4Cr
Other Current Liabilities	14L	15L	5L	14L	27L
Total Current Liabilities	46Cr	57Cr	62Cr	78Cr	83Cr
Long-Term Debt	105.99Cr	105.82Cr	105.66Cr	110.46Cr	115.41Cr
Long-Term Leases	7.45Cr	7.14Cr	8.55Cr	8.48Cr	8.85Cr
Deferred Tax Liability Non Current	-	2.22Cr	3.49Cr	4.76Cr	5.6Cr
Other Non Current Liabilities	2.09Cr	96.83L	-	4L	14.38L
Total Liabilities	161.5Cr	172.68Cr	179.54Cr	201.75Cr	212.94Cr
Common Stock, Total	18T	18T	18T	18T	18T
Additional Paid In Capital	113.89Cr	117.69Cr	120.43Cr	123.14Cr	126.35Cr
Retained Earnings	3.99Cr	19Cr	46Cr	67Cr	88Cr
Treasury Stock	-24.03L	-24.03L	-26Cr	-51Cr	-82Cr
Comprehensive Income and Other	-5L	2.12Cr	1.5Cr	1.1Cr	41.06L
Total Common Equity	117.59Cr	138.61Cr	142.17Cr	140.42Cr	132.64Cr
Total Equity	117.59Cr	138.61Cr	142.17Cr	140.42Cr	132.64Cr
Total Liabilities And Equity	279.09Cr	311.29Cr	321.7Cr	342.17Cr	345.58Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	18Cr	18Cr	17Cr	17Cr	16Cr
ECS Total Common Shares Outstanding	18Cr	18Cr	17Cr	17Cr	16Cr
Book Value / Share	6.54	7.62	8.14	8.45	8.46
Tangible Book Value	-67Cr	-51Cr	-45Cr	-44Cr	-59Cr
Tangible Book Value Per Share	-3.71	-2.81	-2.6	-2.63	-3.76
Total Debt	116.01Cr	115.5Cr	116.64Cr	121.8Cr	127.33Cr
Net Debt	104.07Cr	86Cr	81Cr	80Cr	103.52Cr
Debt Equivalent Oper. Leases	24Cr	23Cr	24Cr	26Cr	28Cr
Equity Method Investments, Total	2.01Cr	1.94Cr	2.09Cr	2.45Cr	2.79Cr
Account Code - Inventory Valuation	5	5	5	5	5
Machinery, Total	5.29Cr	3.19Cr	2.36Cr	2.41Cr	2.81Cr
Full Time Employees	5.43T	5.6T	5.81T	6.02T	6.53T
Part Time Employees	1.81T	2.46T	1.99T	2.07T	1.74T
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	14Cr	15Cr	27Cr	21Cr	21Cr
Depreciation & Amortization - CF	3.59Cr	3.25Cr	2.8Cr	2.91Cr	3.38Cr
Amortization of Goodwill and Intangible Assets - (CF)	3.29Cr	3.29Cr	3.42Cr	3.44Cr	3.69Cr
Depreciation & Amortization, Total	6.88Cr	6.54Cr	6.22Cr	6.35Cr	7.07Cr
Amortization of Deferred Charges, Total - (CF)	49.98L	43.04L	44.46L	46.28L	41.47L
(Gain) Loss From Sale Of Asset	8L	-94.03L	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-31.3L	8L	-15.3L	-35.64L	-34.09L
Stock-Based Compensation (CF)	95.75L	1.68Cr	3.05Cr	3.61Cr	4Cr
Other Operating Activities, Total	-10L	6.89Cr	3.01Cr	3.11Cr	3.92Cr
Change In Accounts Receivable	-42.73L	-3.69Cr	2L	-3.21Cr	-5.46Cr
Change In Inventories	-2.27Cr	-4.1Cr	-5.1Cr	-11Cr	-8.15Cr
Change In Accounts Payable	-1.04Cr	9.89Cr	4.77Cr	18Cr	1.95Cr
Change in Other Net Operating Assets	2.6Cr	-5.08Cr	-1.84Cr	-5.74Cr	1.68Cr
Cash from Operations	21Cr	27Cr	37Cr	32Cr	26Cr
Capital Expenditure	-2.56Cr	-3.54Cr	-4.19Cr	-3.56Cr	-4.13Cr
Sale of Property, Plant, and Equipment	-	1.47Cr	37.43L	-	-
Cash Acquisitions	-8.59Cr	-8.74Cr	-1.25Cr	-	-12Cr
Other Investing Activities, Total	-	-	-58.89L	-9L	-25.29L
Cash from Investing	-11Cr	-11Cr	-5.65Cr	-3.65Cr	-16Cr
Long-Term Debt Issued, Total	86Cr	-	-	5Cr	23Cr
Total Debt Issued	86Cr	-	-	5Cr	23Cr
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-92Cr	-60L	-60L	-63.84L	-19Cr
Total Debt Repaid	-92Cr	-60L	-60L	-63.84L	-19Cr
Issuance of Common Stock	-	2.13Cr	-	-	-
Repurchase of Common Stock	-32T	-	-25Cr	-27Cr	-32Cr
Other Financing Activities, Total	-1.28Cr	-	-57.5L	33.27L	-10.37L
Cash from Financing	-7.69Cr	1.53Cr	-27Cr	-22Cr	-28Cr
Net Change in Cash	2.02Cr	17Cr	4.97Cr	6.87Cr	-18Cr
Supplemental Items
Cash Interest Paid	6.09Cr	5.04Cr	6.98Cr	7.16Cr	6.47Cr
Cash Income Tax Paid (Refund)	57.06L	1.34Cr	7.52Cr	6.45Cr	6.73Cr
Levered Free Cash Flow	14Cr	16Cr	22Cr	24Cr	17Cr
Unlevered Free Cash Flow	18Cr	19Cr	25Cr	26Cr	20Cr
Change In Net Working Capital	-63.74L	33.54L	-26.27L	38.09L	7.78Cr
Net Debt Issued / Repaid	-6.4Cr	-60L	-60L	4.36Cr	4.43Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.39	5.09	6.21	6.06	6.14
Return on Total Capital	5.21	6.16	7.67	7.72	8.09
Return On Equity %	12.77	11.75	19.02	14.99	15.2
Return on Common Equity	12.77	11.75	19.02	14.99	15.2
Margin Analysis
Gross Profit Margin %	22.67	21.98	22.81	20.27	19.26
SG&A Margin	15.29	14.35	14.12	12.61	12.08
EBITDA Margin %	7.55	7.75	8.76	7.71	7.23
EBITA Margin %	6.51	6.92	8.11	7.13	6.63
EBIT Margin %	5.55	6.09	7.31	6.44	5.98
Income From Continuing Operations Margin %	4.07	3.82	6.21	4.24	3.67
Net Income Margin %	4.07	3.82	6.21	4.24	3.67
Net Avail. For Common Margin %	4.07	3.82	6.21	4.24	3.67
Normalized Net Income Margin	2.36	3.26	3.98	3.55	3.18
Levered Free Cash Flow Margin	4.12	4.17	5.17	4.71	3.06
Unlevered Free Cash Flow Margin	5.19	4.91	5.81	5.23	3.59
Asset Turnover
Asset Turnover	1.26	1.34	1.36	1.51	1.64
Fixed Assets Turnover	18.28	21.49	22.32	23.88	25.43
Receivables Turnover (Average Receivables)	10.32	11.02	11.39	12.7	12.79
Inventory Turnover (Average Inventory)	15.56	15.11	13.33	12.04	10.62
Short Term Liquidity
Current Ratio	1.55	1.76	1.77	1.7	1.53
Quick Ratio	1.09	1.28	1.27	1.13	0.9
Operating Cash Flow to Current Liabilities	0.45	0.47	0.6	0.41	0.31
Days Sales Outstanding (Average Receivables)	35.38	33.11	32.03	28.83	28.53
Days Outstanding Inventory (Average Inventory)	23.45	24.16	27.38	30.41	34.38
Average Days Payable Outstanding	38.23	38.5	43.6	46.31	49.14
Cash Conversion Cycle (Average Days)	20.6	18.77	15.82	12.93	13.77
Long Term Solvency
Total Debt/Equity	98.66	83.33	82.04	86.74	96
Total Debt / Total Capital	49.66	45.45	45.07	46.45	48.98
LT Debt/Equity	96.47	81.5	80.34	84.7	93.68
Long-Term Debt / Total Capital	48.56	44.45	44.13	45.36	47.8
Total Liabilities / Total Assets	57.87	55.47	55.81	58.96	61.62
EBIT / Interest Expense	2.85	4.46	6.14	6.56	6.19
EBITDA / Interest Expense	4.32	6.22	7.95	8.53	8.13
(EBITDA - Capex) / Interest Expense	3.94	5.56	7.13	7.8	7.38
Total Debt / EBITDA	4.01	3.45	2.86	2.91	2.87
Net Debt / EBITDA	3.6	2.57	2	1.91	2.33
Total Debt / (EBITDA - Capex)	4.4	3.86	3.19	3.18	3.16
Net Debt / (EBITDA - Capex)	3.94	2.88	2.22	2.09	2.57
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.39	14.72	9.06	16.17	13.03
Gross Profit, 1 Yr. Growth %	14.27	11.2	13.19	3.24	7.39
EBITDA, 1 Yr. Growth %	37.63	17.72	23.27	2.27	6.04
EBITA, 1 Yr. Growth %	53.4	22.07	27.7	2.13	5.21
EBIT, 1 Yr. Growth %	72.31	25.88	30.96	2.3	4.99
Earnings From Cont. Operations, 1 Yr. Growth %	-1.83T	7.62	77.4	-20.69	-2
Net Income, 1 Yr. Growth %	-1.83T	7.62	77.4	-20.69	-2
Normalized Net Income, 1 Yr. Growth %	1.96T	58.43	40.1	3.71	1.27
Diluted EPS Before Extra, 1 Yr. Growth %	-1.83T	7.79	78.31	-16.89	3.25
Accounts Receivable, 1 Yr. Growth %	3.02	11.62	0.03	8.49	15.58
Inventory, 1 Yr. Growth %	15.44	22.49	22.17	41.65	21.39
Net Property, Plant and Equip., 1 Yr. Growth %	-1.91	-2.99	13.3	4.45	7.76
Total Assets, 1 Yr. Growth %	5.42	11.54	3.34	6.36	0.99
Tangible Book Value, 1 Yr. Growth %	-12.6	-23.4	-11.24	-3.73	34.9
Common Equity, 1 Yr. Growth %	15.77	17.88	2.57	-1.23	-5.54
Cash From Operations, 1 Yr. Growth %	63.72	28.28	38.78	-12.9	-20.08
Capital Expenditures, 1 Yr. Growth %	-4.63	37.94	18.41	-14.95	16.01
Levered Free Cash Flow, 1 Yr. Growth %	56.15	16.12	26.95	5.79	-26.6
Unlevered Free Cash Flow, 1 Yr. Growth %	17	8.55	22.23	4.52	-22.45
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	22	14.05	11.86	12.56	14.59
Gross Profit, 2 Yr. CAGR %	23.28	12.72	12.19	8.1	5.3
EBITDA, 2 Yr. CAGR %	76.5	27.29	20.47	12.28	4.13
EBITA, 2 Yr. CAGR %	108.27	36.84	24.86	14.2	3.66
EBIT, 2 Yr. CAGR %	173.67	47.28	28.39	15.74	3.64
Earnings From Cont. Operations, 2 Yr. CAGR %	35.75	331.77	38.17	18.61	-11.84
Net Income, 2 Yr. CAGR %	35.75	331.77	38.17	18.61	-11.84
Normalized Net Income, 2 Yr. CAGR %	66.37	471.41	45.21	20.54	2.48
Diluted EPS Before Extra, 2 Yr. CAGR %	25.36	331.27	38.64	21.73	-7.37
Accounts Receivable, 2 Yr. CAGR %	2.11	7.23	5.67	4.18	11.98
Inventory, 2 Yr. CAGR %	25.7	18.92	22.33	31.55	31.13
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.68	-2.45	4.84	8.78	6.09
Total Assets, 2 Yr. CAGR %	3.82	8.44	7.36	4.84	3.64
Tangible Book Value, 2 Yr. CAGR %	-14.09	-18.18	-17.54	-7.56	13.96
Common Equity, 2 Yr. CAGR %	13.87	16.82	9.96	0.65	-3.41
Cash From Operations, 2 Yr. CAGR %	129.88	44.92	33.42	9.94	-16.57
Capital Expenditures, 2 Yr. CAGR %	-4.82	14.7	27.8	0.35	-0.67
Levered Free Cash Flow, 2 Yr. CAGR %	315.71	34.65	25.38	15.89	-11.88
Unlevered Free Cash Flow, 2 Yr. CAGR %	89.42	12.7	18.39	13.03	-9.97
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	21.03	19.52	12.36	13.28	12.72
Gross Profit, 3 Yr. CAGR %	22.68	19.11	12.88	9.12	7.86
EBITDA, 3 Yr. CAGR %	48.48	54.21	25.94	14.06	10.16
EBITA, 3 Yr. CAGR %	56.95	74.3	33.73	16.77	11.12
EBIT, 3 Yr. CAGR %	70.85	111.25	41.62	19.03	12.04
Earnings From Cont. Operations, 3 Yr. CAGR %	183.88	25.64	220.99	14.83	11.3
Net Income, 3 Yr. CAGR %	183.88	25.64	220.99	14.83	11.3
Normalized Net Income, 3 Yr. CAGR %	145.59	63.68	251.57	29.8	13.74
Diluted EPS Before Extra, 3 Yr. CAGR %	161.87	19.2	221.29	16.9	15.23
Accounts Receivable, 3 Yr. CAGR %	2.92	5.19	4.78	6.6	7.85
Inventory, 3 Yr. CAGR %	30	24.62	19.99	28.46	28.07
Net Property, Plant and Equip., 3 Yr. CAGR %	26	-2.78	2.54	4.71	8.44
Total Assets, 3 Yr. CAGR %	25.02	6.33	6.71	7.03	3.54
Tangible Book Value, 3 Yr. CAGR %	38.86	-17.31	-15.93	-13.18	4.85
Common Equity, 3 Yr. CAGR %	24.95	15.19	11.86	6.09	-1.46
Cash From Operations, 3 Yr. CAGR %	104.39	89.26	42.84	15.74	-1.15
Capital Expenditures, 3 Yr. CAGR %	-0.82	7.71	15.92	11.58	5.32
Levered Free Cash Flow, 3 Yr. CAGR %	668.24	171.74	34.9	18.48	-0.48
Unlevered Free Cash Flow, 3 Yr. CAGR %	90.4	57.33	17.93	13.58	-0.31
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.5	17.22	17.27	16.69	13.25
Gross Profit, 5 Yr. CAGR %	13.67	16.71	18.37	14.58	9.78
EBITDA, 5 Yr. CAGR %	25.05	36.15	36.57	35.83	16.72
EBITA, 5 Yr. CAGR %	25.23	42.14	43.23	47.18	20.78
EBIT, 5 Yr. CAGR %	29.48	54.51	52.4	66.07	24.99
Earnings From Cont. Operations, 5 Yr. CAGR %	104.52	107.88	112.84	22.78	91.43
Net Income, 5 Yr. CAGR %	104.52	107.88	112.84	22.78	91.43
Normalized Net Income, 5 Yr. CAGR %	64.11	69.5	99.03	43.34	114.71
Diluted EPS Before Extra, 5 Yr. CAGR %	-	98.12	103.05	20.21	95.36
Accounts Receivable, 5 Yr. CAGR %	-	5.69	4.01	4.78	7.6
Inventory, 5 Yr. CAGR %	-	20.34	26.88	27.35	24.33
Net Property, Plant and Equip., 5 Yr. CAGR %	-	15.23	17.07	1.69	3.94
Total Assets, 5 Yr. CAGR %	-	16.73	17.63	5.73	5.47
Tangible Book Value, 5 Yr. CAGR %	-	14.21	12.73	-13.54	-5.05
Common Equity, 5 Yr. CAGR %	-	17.99	18.72	9.14	5.48
Cash From Operations, 5 Yr. CAGR %	19.36	47.85	72.33	52.3	15.2
Capital Expenditures, 5 Yr. CAGR %	-7.67	7.22	9.76	4.71	8.98
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	272.04	95.75	13.77
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	57.45	39.36	5.86